|
2025
|
Invention
|
Methods and compositions for monitoring the treatment of relapsed and/or refractory multiple myel... |
|
|
Invention
|
Safe and effective method of treating psoriatic arthritis with anti-il23 specific antibody.
A me... |
|
|
Invention
|
Materials, methods and systems for cellular redifferentiation and expansion.
Materials, methods,... |
|
|
Invention
|
Bispecific antibody targeting emr2 (cd312) and the t-cell receptor trbv19.
Provided herein are m... |
|
|
Invention
|
Methods for treating multiple myeloma. Embodiments of the present invention relate to methods of ... |
|
|
Invention
|
Bispecific antibody targeting emr2 (cd312) and the t-cell receptor trbv19. Provided herein are mu... |
|
|
Invention
|
Compositions and methods for the treatment of prostate cancer. Compositions and methods for the t... |
|
|
Invention
|
Subcutaneous formulations of anti-cd38 antibodies and their uses.
The present invention relates ... |
|
|
Invention
|
Methods for treating multiple myeloma with car-t cells and bispecific antibodies. Provided herein... |
|
|
Invention
|
Materials, methods, and systems for cellular expansion of gamma delta t-cells. Provided is a seru... |
|
|
Invention
|
Lipase degradation resistant surfactants for use in large molecule therapeutic formulations.
The... |
|
|
Invention
|
Klk2xcd3 antibody and an anti-cancer agent for treating prostate cancer. The application describe... |
|
|
Invention
|
Ltbr binding molecules and uses thereof. Provided herein are anti-LTßR multispecific binding mole... |
|
|
Invention
|
Ltbr binding molecules and uses thereof. Provided herein are anti-LTβR multispecific binding mole... |
|
|
Invention
|
Materials and methods for targeting regulatory t cells for enhancing immune surveillance.
A mole... |
|
|
Invention
|
Materials, methods and systems for cellular redifferentiation and expansion. Materials, methods, ... |
|
|
Invention
|
Methods for predicting treatment response in psoriasis.
The disclosure provides a method of pred... |
|
|
Invention
|
Methods for predicting treatment response in psoriasis. The disclosure provides a method of predi... |
|
|
Invention
|
Methods of treating crohn's disease with anti-il23 specific antibody.
A method of treating Crohn... |
|
|
Invention
|
Methods of treating crohn's disease with anti-il23 specific antibody. A method of treating Crohn'... |
|
|
Invention
|
Bcma-targeted car-t cell therapy for multiple myeloma.
Provided herein are methods of treating a... |
|
|
Invention
|
Use of bispecific anti-egfr/c-met antibodies to treat solid tumors. The present invention relates... |
|
|
Invention
|
Bcma-targeted car-t cell therapy for multiple myeloma. Provided herein are methods of treating a ... |
|
|
Invention
|
Combinations of oncolytic viruses and immunomodulators. Provided herein are methods of treatment ... |
|
|
Invention
|
Oncolytic viruses expressing immunomodulators and use for treating advanced solid tumor. Provided... |
|
|
Invention
|
Anti-vbeta17/anti-cd123 bispecific antibodies.
Anti-Vβ17/anti-CD123 bispecific antibodies or ant... |
|
|
Invention
|
Materials and methods for biologic affinity analysis. A method for determining the affinity of an... |
|
|
Invention
|
Anti-transferrin receptor compositions and methods thereof. The application describes anti-TfR an... |
|
|
Invention
|
Method of treating ulcerative colitis with an antibody to il-23.
A method of treating inflammato... |
|
|
Invention
|
Materials and methods for designing, use and manufacture of improved biologic molecules. Material... |
|
|
Invention
|
Ovarian neoantigens and use thereof. Disclosed herein are methods and compositions for treating o... |
|
|
Invention
|
Use of amivantamab to treat head and neck cancer. The present invention relates to methods of tre... |
|
|
Invention
|
Use of amivantamab to treat colorectal cancer.
The present invention relates to methods of treat... |
|
|
Invention
|
Patch assembly configured to facilitate needle insertion into a patient and delivery of medicamen... |
|
|
Invention
|
Use of amivantamab to treat colorectal cancer. The present invention relates to methods of treati... |
|
|
Invention
|
Injection aid, and method of making and using same. An injection aid can include a housing and an... |
|
2024
|
Invention
|
Combination therapies and patient stratification with bispecific ant-egfr/c-met antibodies.
The ... |
|
|
Invention
|
Differentiation of human embryonic stem cells into single hormonal insulin positive cells.
The p... |
|
|
Invention
|
Methods for treating multiple myeloma.
Embodiments of the present invention relate to methods of... |
|
2023
|
Invention
|
Drug delivery system |
|
|
Invention
|
Patient trainer mirror.
The present invention is a smart mirror device that provides custom guid... |
|
|
Invention
|
Accessory for injection device.
In one example, an accessory for a drug injection device has a p... |
|
2022
|
Invention
|
Compositions comprising enhanced multispecific binding agents for an immune response.
Disclosed ... |
|
|
Invention
|
Biosynthetic bioparatopic or bispecific binding molecules with enhanced effector functions.
Prov... |
|
|
Invention
|
Dynamic nutrient control processes.
Materials and methods to control a nutrient feed in a cell c... |
|
|
Invention
|
Immunoconjugates comprising kallikrein related peptidase 2 antigen binding domains and their uses... |
|
2020
|
Invention
|
Optimized culture media for clostridia bacteria.
The present invention relates to media composit... |
|
2019
|
P/S
|
Operating an online-marketplace featuring cell and gene therapy treatments and services; business... |
|
2016
|
P/S
|
Software as a service (SAAS) services, namely, hosting software for use by others for ordering, t... |
|
2008
|
P/S
|
Pharmaceutical and veterinary preparations, pharmaceutical preparations for the prevention and tr... |
|
2007
|
P/S
|
patient assistance program, namely, financial assistance for patients receiving pharmaceutical pr... |
|
2003
|
P/S
|
Pharmaceutical for the treatment of autoimmune diseases and autoimmune disorders. |
|
2002
|
P/S
|
pharmaceutical preparations for the treatment of autoimmune diseases and autoimmune disorders |
|
2001
|
P/S
|
Medical device used to infuse pharmaceuticals. |
|
|
P/S
|
Pharmaceutical for treatment of autoimmune diseases and disorders. |
|
1998
|
P/S
|
Pharmaceutical and medical preparations and substances; pharmaceutical compositions for the treat... |
|
|
P/S
|
Pharmaceutical compositions for treatment of autoimmune diseases and disorders. |
|
|
P/S
|
Pharmaceutical compositions for treatment of autoimmune diseases and disorders |
|
1996
|
P/S
|
Pharmaceutical preparations and products. |
|
1994
|
P/S
|
Pharmaceutical preparations for prevention and treatment of disease of the circulatory system. |
|
|
P/S
|
pharmaceutical preparations for the prevention and treatment of diseases of the circulatory system |
